• ASP Isotopes outlined plans to scale isotope enrichment capacity across electronics, nuclear medicine, and nuclear energy end-markets.
• Management targets first commercial shipments of Silicon-28, Carbon-14, and Ytterbium-176 in 2H 2026.
• Virginia Gas Project targets helium production before Sep. 30, 2026; nameplate capacity expected in 3Q 2026.
• Phase 2 expansion targets USD 750 million of senior debt funding, including USD 500 million from DFC plus USD 250 million from Standard Bank SA.
• Management set an EBITDA target above USD 300 million in 2031.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ASP Isotopes Inc. published the original content used to generate this news brief on August 24, 2026, and is solely responsible for the information contained therein.